Provider Alert! Clinical Implementation of Hormonal Therapy Agents Clinical Prior Authorization Effective March 1, 2024
Date: February 1, 2024 Attention: All Providers Effective Date: March 1, 2024 Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that effective March 1, 2024, the Texas Health and Human Services (HHSC) will implement clinical prior authorizations to hormonal therapy agents. HHSC will implement criteria for the following procedure codes: J1000 (depo-estradiol cypionate, up to 5mg) J1071 (inj testosterone cypionate, 1 mg) J1380 (inj estradoiol valerate, up to 10 mg) J1950 (inj leuprolide acetate, per 3.75 mg) J1951 (inj leuprolide acetate, fensolvi, 0.25...
